Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWNASDAQ:DHAIWNASDAQ:HSKA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-5.9%$0.11$0.03▼$0.37N/AN/A20,087 shs1,700 shsBBLGWBone Biologics$16.90-16.3%$20.63$3.00▼$95.04N/AN/A2,106 shs200 shsDHAIWDIH Holding US$0.02+26.9%$0.02$0.01▼$0.13N/AN/A179,451 shs7,384 shsHSKAHeska$119.99$119.09$57.83▼$120.03$1.31B1.58241,932 shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos-5.88%+27.97%-8.48%+0.49%+29.75%BBLGWBone Biologics0.00%-16.34%-16.34%-76.53%-26.65%DHAIWDIH Holding US+40.00%-21.19%-11.85%-69.87%-66.00%HSKAHeska0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/AN/AN/AN/AHSKAHeskaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ADHAIWDIH Holding US 0.00N/AN/AN/AHSKAHeska 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$20.73KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ADHAIWDIH Holding US$64.47MN/AN/AN/AN/AN/AHSKAHeska$257.31M5.09$1.69 per share70.99$39.00 per share3.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/A0.00∞N/AN/AN/AN/AN/AHSKAHeska-$19.89M-$1.93N/A83.33N/A-7.86%0.94%0.67%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AN/AN/AHSKAHeskaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMDWAinosN/AN/AN/ABBLGWBone BiologicsN/AN/AN/ADHAIWDIH Holding USN/AN/AN/AHSKAHeska0.235.644.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/AHSKAHeska99.01%Insider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ADHAIWDIH Holding USN/AHSKAHeska12.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableDHAIWDIH Holding USN/AN/AN/AN/AHSKAHeska80810.91 million9.57 millionNot OptionableHSKA, AIMDW, BBLGW, and DHAIW HeadlinesRecent News About These CompaniesARUP Awarded CDC Contract for Bird Flu Test DevelopmentSeptember 14, 2024 | medindia.netAmbrosia Biosciences launches with $16M investment, Array chemistry teamAugust 23, 2024 | bizwest.comAntech opens R&D lab at former Heska facilityAugust 21, 2024 | bizwest.comFlights to HuescaMay 3, 2024 | skyscanner.netBest Medical-Only DispensaryApril 30, 2024 | westword.comVolitionRx Shares Up 35% on $13M Milestone Payments From HeskaJanuary 2, 2024 | marketwatch.comWhy Heska (HSKA) Hit a One-Year High TodayOctober 31, 2023 | thestreet.comKassala Airport, Kassala, Sudan [ KSL / HSKA ]June 24, 2023 | prokerala.comMars completes $1.3B acquisition of HeskaJune 15, 2023 | bizwest.comWhy eXp World Holdings Shares Are Rising ThursdayJune 8, 2023 | markets.businessinsider.comKeeping an Eye on Heska Corporation (HSKA) After Insider Trading ActivityJune 7, 2023 | knoxdaily.comHeska Earnings Perspective: Return On Capital EmployedMay 19, 2023 | msn.comSG Americas Securities LLC Trims Stake in Heska Co. (NASDAQ ... - MarketBeatMay 14, 2023 | news.google.comVeterinary Ultrasound Imaging GE Healthcare, Agfa-Gevaert N.V. ... - Digital JournalMay 13, 2023 | news.google.comVeterinary Chemistry Analyzers Market 2023 by Keyplayers and ... - StreetBuzzMay 13, 2023 | news.google.comSG Americas Securities LLC trims Heska Co. holdings by 72 ... - Best StocksMay 13, 2023 | news.google.comVolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update - Yahoo FinanceMay 12, 2023 | news.google.comAnimal/Veterinary Ultrasound Market to Eyewitness Massive Growth ... - Cottonwood Holladay JournalMay 11, 2023 | news.google.comAnimal Ultrasound Market Global Production, Growth, Share and ... - Digital JournalMay 11, 2023 | news.google.comHESKA CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Heska ...May 11, 2023 | businesswire.comMedia Sentiment Over TimeHSKA, AIMDW, BBLGW, and DHAIW Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.01 (-5.88%) As of 04/24/2025 10:01 AM EasternAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$16.90 -3.30 (-16.34%) As of 04/24/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.DIH Holding US NASDAQ:DHAIW$0.02 +0.00 (+26.89%) As of 03:16 PM EasternDIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.Heska NASDAQ:HSKAHeska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Market Anticipation Builds: Joby Stock Climbs Ahead of Earnings Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? Now Is the Time to Buy ServiceNow—The Rebound Is Real Archer Aviation Gets Analyst Target Upgrade: Time to Load Up? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
